Add SubjectMark | Show Original Post | Show Chart | Poster Summary |Clinuvel Pharmaceuticals Ltd | Stock Discussion Forums Share This Board

Reply	Message Preview	From	Recs	Date
40	Clinuvel commences US Phase III trial of SCENESSE® in rare light and UV di	caly	-	05/22/2012 07:14 AM
39	Clinuvel, FDA agree in principle to Phase III study with SCENESSE® (afame	caly	-	03/15/2012 09:02 AM
38	Clinuvel demonstrates positive treatment effect of afamelanotide in US Phase	caly	-	11/03/2011 08:55 AM
37	Clinuvel records first A$1 million in sales Successful first year of drug supp	caly	-	06/23/2011 10:59 AM
36	Letter to shareholders: clinuvel.com	caly	-	04/18/2011 11:52 PM
35	FDA allows Clinuvel’s innovative vitiligo trial facebook.com	caly	-	03/02/2011 09:16 PM
34	A clinical success: study retention rates clinuvel.com	caly	-	02/10/2011 11:25 AM
33	Clinuvel completes first Phase II US study Last patient visit completes confi	caly	-	02/08/2011 05:16 PM
32	biotechnologynews.net	caly	-	01/11/2011 07:46 PM
31	Tuesday 16th November 2010 Melbourne, Australia TGA grants Orphan Drug Designat	caly	-	11/15/2010 11:42 PM
30	Company Announcement Tuesday 9th November 2010 Melbourne, Australia FDA provide	caly	-	11/08/2010 07:47 PM